Publications by authors named "Shams S M Tabrez"

Introduction: Autoimmune hepatitis (AIH) is a chronic inflammatory condition of the liver with increasing global prevalence. However, no epidemiological data exist for AIH in human immunodeficiency virus (HIV)-infected patients.

Aim: To determine the demographics and comorbid conditions associated with AIH among HIV-infected individuals in the United States.

View Article and Find Full Text PDF

A global outbreak highlights the start of a new decade as a new strain of coronaviruses emerges. Coronavirus disease 2019 (COVID-19), also referred to as Wuhan-Hu-1-CoV - amongst many other names - emerged from the West District of Southern China Seafood Wholesale Market in late December 2019. With the emergence of the new decade, the causative agent of COVID-19 was identified: severe acute respiratory syndrome coronavirus 2 (SARS-CoV2).

View Article and Find Full Text PDF

The treatment of () induced infections using antibiotic therapies is clinically well accepted; however, using a noninvasive approach with the implementation of therapeutic agents such as vitamin C is not well investigated. Vitamin C has certain characteristics, which allow for it to be considered as a potential treatment option for patients with infections. Vitamin C's hostility and mechanism of action towards infection in peptic ulcer disease can be classified into two categories: as a preventative agent and alternatively as a therapeutic agent.

View Article and Find Full Text PDF

Energy drink consumption has caused worldwide concern in the scientific community and the general public regarding the health effects of these products. Current studies offer data about consumption patterns in America and Europe, but more extensive research is needed to ascertain the potential effects of energy drink consumption, especially among young and healthy individuals. To examine the consequences and health risks of energy drink consumption, related studies were reviewed.

View Article and Find Full Text PDF
Article Synopsis
  • - Gastroesophageal reflux disease (GERD) is a chronic illness affecting 10% to 20% of adults in Western countries, with about 30 million cases in the U.S.
  • - Approximately 60% of adults will experience GERD symptoms within a year, and 20% to 30% will have weekly symptoms, indicating a growing epidemic.
  • - While there is no cure for GERD, various management techniques, including pharmacological and surgical options, can help patients lead healthy lives by alleviating symptoms.
View Article and Find Full Text PDF